Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cytokeratin 13
Path
Created with Sketch.
Go to Cytokeratin 13 Normal Tissue Gallery
Go back to Product Page
Anorectum - Squamous cell carcinoma with moderate to strong KRT13 positivity of suprabasal cells.
Anorectum – Squamous cell carcinoma with moderate to strong KRT13 positivity of suprabasal cells.
Colon - KRT13 negative colorectal adenocarcinoma.
Colon – KRT13 negative colorectal adenocarcinoma.
Esophgus - Squamous cell carcinoma with strong diffuse KRT13 positivity.
Esophgus – Squamous cell carcinoma with strong diffuse KRT13 positivity.
Kidney - KRT13 negative clear cell renal cell carcinoma.
Kidney – KRT13 negative clear cell renal cell carcinoma.
Larynx - Squamous cell carcinoma with intense KRT13 positivity of suprabasal cells.
Larynx – Squamous cell carcinoma with intense KRT13 positivity of suprabasal cells.
Lung - KRT13 negative adenocarcinoma.
Lung – KRT13 negative adenocarcinoma.
Lung - Squamous cell carcinoma with intense KRT13 positivity of all cells. KRT13 staining intensity increases from the basal cell layers to the center of invasive tumor cell nests.
Lung – Squamous cell carcinoma with intense KRT13 positivity of all cells. KRT13 staining intensity increases from the basal cell layers to the center of invasive tumor cell nests.
Ovary - Brenner tumor with strong KRT13 positivity of urothelial cells.
Ovary – Brenner tumor with strong KRT13 positivity of urothelial cells.
Penis - Squamous cell carcinoma exhibiting a strong diffuse KRT13 positivity of all tumor cells.
Penis – Squamous cell carcinoma exhibiting a strong diffuse KRT13 positivity of all tumor cells.
Pleura - KRT13 negative malignant mesothelioma.
Pleura – KRT13 negative malignant mesothelioma.
Prostate - KRT13 negative prostatic adenocarcinoma (Gleason 3+3=6).
Prostate – KRT13 negative prostatic adenocarcinoma (Gleason 3+3=6).
Salivary gland - Warthin tumor showing intense KRT13 positivity of a small fraction of (suprabasal) cells.
Salivary gland – Warthin tumor showing intense KRT13 positivity of a small fraction of (suprabasal) cells.
Skin - KRT13 negative basal cell carcinoma.
Skin – KRT13 negative basal cell carcinoma.
Skin - Squamous cell carcinoma with scattered KRT13 positive cells showing variable levels of expression (mosaic pattern).
Skin – Squamous cell carcinoma with scattered KRT13 positive cells showing variable levels of expression (mosaic pattern).
Thyroid - KRT13 negative papillary carcinoma.
Thyroid – KRT13 negative papillary carcinoma.
Urinary bladder - Non-invasive papillary urothelial carcinoma (pTa) showing strong diffuse KRT13 positivity.
Urinary bladder – Non-invasive papillary urothelial carcinoma (pTa) showing strong diffuse KRT13 positivity.
Urinary bladder - Strong KRT13 immunostaining in a muscle-invasive urothelial carcinoma.
Urinary bladder – Strong KRT13 immunostaining in a muscle-invasive urothelial carcinoma.
Uterine cervix - Squamous cell carcinoma showing strong KRT13 expression of suprabasal cells.
Uterine cervix – Squamous cell carcinoma showing strong KRT13 expression of suprabasal cells.
Vulva - Squamous cell carcinoma with intense KRT13 immunostaining of all cells.
Vulva – Squamous cell carcinoma with intense KRT13 immunostaining of all cells.